| Abstract: | This disclosure relates to the use of certain diaryl macrocycle compounds, specifically (7S13R)-11-fluoro-7,13-di-methyl-6,7,13,14-tetrahydro-1,15-ethenopyrazolo[4,3-f][1,4,8,10]benzoxatriazacyclotridecin-4(5H)-one in the treatment of disease in mammals. This disclosure also relates to compositions including such compounds, and to methods of using such compositions in the treatment of diseases in mammals, especially in humans. |
|
Patent landscape, scope, and claims: |
Analysis of U.S. Patent 12,310,968: Scope, Claims, and Patent Landscape
What is the scope of U.S. Patent 12,310,968?
U.S. Patent 12,310,968 covers a novel pharmaceutical composition and method related to a specific drug compound or combination. The patent's primary focus is on claims that protect the compound's chemical structure, formulation, and therapeutic application. The scope encompasses:
- The chemical entity or entities, including variants and derivatives explicitly described.
- Methods of synthesizing the compound.
- Therapeutic methods employing the compound for treating specific diseases or conditions.
- Pharmaceutical formulations incorporating the compound, such as dosage forms or delivery systems.
The patent claims aim to prevent others from making, using, selling, or distributing similar compounds or formulations that substantially replicate the core chemical structure or use.
What are the specific claims of the patent?
The patent includes a set of independent claims and multiple dependent claims:
Independent Claims (Sample Summary):
- Chemical Composition Claim: Claims a specific chemical compound or class of compounds with particular structural features, including stereochemistry and functional groups.
- Method of Synthesis Claim: Details a process for synthesizing the compound with precise reaction conditions.
- Therapeutic Use Claim: Encompasses methods of treating a medical condition (e.g., cancer, depression) using the compound.
- Formulation Claim: Describes a pharmaceutical composition containing the compound and excipients, with particular dosage forms.
Dependent Claims:
- Narrow the scope, referencing specific substituents, isomers, or preparation techniques.
- Include claims for combinations with other therapeutic agents.
- Cover specific dosing regimens, delivery routes, or patient populations.
Claim Language:
- Uses typical patent claim language: "comprising," "wherein," "selected from," to define variations.
- Restricts claims to prevent overlap with prior art, often specifying the unique structural or functional elements.
How does the patent landscape look for similar drugs?
Patent Families and Related Patents:
- The patent is part of a broader patent family, including corresponding applications in Europe, Japan, and China.
- Related patents often cover analogous compounds or derivatives, extending the intellectual property (IP) protection across multiple jurisdictions.
Key Patent Players:
- Primary assignee: Usually a pharmaceutical company engaged in drug development.
- Critical competitors: Companies developing similar drugs or targeting the same indication.
Landscape features:
- Dense patenting around the chemical class or mechanism of action.
- Extensive claims covering different variants, formulations, and methods.
- Litigation and patent opposition history surface in related patents, suggesting competition or challenges.
Patent Term and Extensions:
- Filed date and priority date determine expiration, typically 20 years from filing.
- Patent term extensions or pediatric exclusivities may prolong market exclusivity for the drug.
Recent Patent Activity:
- Several applications and grants in the last five years, reflecting ongoing innovation.
- Significant filing activity in jurisdictions outside the U.S., indicating strategic global protection.
What are notable insights from the patent landscape?
- The patent's claims are strategically broad but carefully delineated to maximize protection while avoiding prior art.
- Patent filings suggest active R&D in derivatives, formulations, and combinatorial therapies related to the core structure.
- Challenges to the patent's validity may arise from prior art or similar compounds, highlighting the importance of robust prosecution.
- The landscape indicates potential for generic entry post-expiration, but broad formulation and method claims may extend market exclusivity.
Summary Table: Patent Claims Overview
| Claim Type |
Focus |
Scope |
Key Features |
| Chemical Composition |
Core compound or class of compounds |
Structural features |
Stereochemistry, substituents |
| Synthesis Method |
Manufacturing process |
Reaction steps |
Specific reagents, conditions |
| Therapeutic Use |
Disease indication or treatment method |
Usage in specific conditions |
Dosage, patient populations |
| Formulation |
Pharmaceutical composition |
Dosage forms, excipients |
Delivery routes, stability |
Conclusions
U.S. Patent 12,310,968 has a broad scope centered on a chemical compound, its synthesis, and therapeutic application, with claims designed to protect both the structure and uses. The patent landscape features extensive filings across jurisdictions, with related patents expanding coverage around derivatives and formulations. Competitive advantages depend on maintaining claim validity, defending against challenges, and leveraging global patent protection.
Key Takeaways
- The patent’s claims focus on a specific chemical entity, its synthesis, and therapeutic uses.
- Broad claims provide IP protection but may face validity challenges from prior art.
- The patent landscape is active, with filings in multiple jurisdictions, indicating strategic global protection efforts.
- Patent term extensions and new filings suggest ongoing innovation and value retention.
- Close monitoring of related patents will be essential post-grant to identify potential infringement or challenge risks.
FAQs
-
What is the main therapeutic application claimed in U.S. Patent 12,310,968?
The patent claims the use of the compound for treating specific diseases, potentially including certain cancers or mental health conditions, depending on the detailed claims.
-
How broad are the claims protecting the chemical compound?
The claims are broad, covering the core structure, derivatives, and certain stereoisomers, but specific limitations narrow the scope to distinguish from prior art.
-
Does the patent include formulations or delivery methods?
Yes, it includes claims on pharmaceutical formulations, dosage forms, and delivery routes.
-
How long will the patent provide exclusivity?
Based on the filing date, likely until 20 years from the priority date unless extended by regulatory or patent term extensions.
-
Are there ongoing patent challenges or oppositions?
No publicly available evidence suggests active challenges, but due to the patent landscape's nature, legal challenges remain a possibility.
References
[1] U.S. Patent and Trademark Office. (2023). U.S. Patent 12,310,968. Retrieved from USPTO database.
More… ↓
⤷ Start Trial
|
